Benzinga | Nov 5, 2021 09:29AM EDT

Guardant Health Q3 EPS $(0.70) Beats $(0.96) Estimate, Sales $94.78M Beat $92.64M Estimate

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0.96) by 27.08 percent. This is a 10.26 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $94.78 million which beat the analyst consensus estimate of $92.64 million by 2.31 percent. This is a 27.10 percent increase over sales of $74.57 million the same period last year.